Unit of Innovative Techniques in Surgery, European Institute of Oncology, University of Milan, Italy.
University of Milan, Milan, Italy.
Crit Rev Oncol Hematol. 2018 Dec;132:161-168. doi: 10.1016/j.critrevonc.2018.10.002. Epub 2018 Oct 13.
Cancer of the esophagus and of gastroesophageal junction can be cured, even if with lacking cure rate. Different approaches have been developed, mostly when carcinoma has loco-regional pattern. Multimodality therapy showed a survival rate superior than 10% if compared to a single approach. This is a systematic review, carried to assess the following matters: Which therapeutic opportunities are available? Who could benefit of them? Which adverse reactions could possibly verify? How can physicians definitely choose the proper strategy? Which is the role of surgery? We mean to give either General Practitioner or specialists clear and efficient updates about current treatment of this tumour, starting from physical examination. Four eminent guidelines were consulted for our study: Cancer Care Ontario's Program in Evidence-Based Care, NCCN, Belgian Health Care Knowledge Centre and Esmo.
食管癌和胃食管结合部癌即使治愈率低,也可以治愈。已经开发出了不同的治疗方法,主要是在局部区域性癌的情况下。与单一方法相比,多模式治疗显示出 10%以上的生存率。这是一项系统评价,旨在评估以下问题:有哪些治疗机会?谁能从中受益?可能会出现哪些不良反应?医生如何才能确定选择适当的策略?手术的作用是什么?我们旨在为全科医生或专家提供关于这种肿瘤的当前治疗的清晰有效的更新,从体格检查开始。我们的研究咨询了四个著名的指南:安大略省癌症护理计划在循证护理、NCCN、比利时卫生保健知识中心和 Esmo。